Filing Details

Accession Number:
0000899243-16-017712
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-05 20:58:10
Reporting Period:
2016-04-01
Filing Date:
2016-04-05
Accepted Time:
2016-04-05 20:58:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609809 Seres Therapeutics Inc. MCRB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1233684 N David Cook C/o Seres Therapeutics, Inc.
215 First Street
Cambridge MA 02142
Chief Scientific Officer & Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-04-01 46,650 $25.74 183,023 No 4 S Direct
Common Stock Disposition 2016-04-01 6,350 $26.90 176,673 No 4 S Direct
Common Stock Disposition 2016-04-04 8,000 $28.00 168,673 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $25.27 to $26.21. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $26.32 to $27.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.